Does Medicare Cover People’s Spouses?

Translate to Spanish or other 102 languages!

The spouse of a Medicare plan holder becomes eligible for their own plan when they turn 65 years old, even if they never worked outside the home. Image for illustration purposes
The spouse of a Medicare plan holder becomes eligible for their own plan when they turn 65 years old, even if they never worked outside the home. Image for illustration purposes
- Advertisement -

Medicare does not specifically cover spouses. However, some people qualify based on their spouse’s or a former spouse’s work record. 

Some people may qualify for Medicare by reaching age 65 years and having their own eligible work and tax records. Others, however, may not have worked for the required number of quarters.

Follow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/does-medicare-cover-peoples-spouses?slot_pos=article_2&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-01-07&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f#spouse-coverage

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Dogs Benefit Mind and Soul

"Dogs are wonderful greeters. They're waiting for you to come home, and they're always happy to see you. In turn, this increases our feel-good hormones, like dopamine and serotonin,” explained Chivonna Childs, PhD.

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -